Recital 9, Regulation (EU) 2025/1399

In forcesince 5 May 2025

Points 3 and 10 of the PFOA entry set out an obligation for the Commission to review the UTC limits for PFOA, its salts and PFOA-related compounds with regard to certain medical devices and substances to be used as a transported isolated intermediate. There is currently no information supporting a change in such limits. Considering that the Commission can amend the PFOA entry if new information becomes available, the review clauses should be deleted.